Venus Consent Decree Shows Cost Of Flouting GMP Warning

Venus Pharmaceuticals International agrees to stop production and distribution of supplements in the U.S. and internationally, and to recall and destroy affected product made prior to January 2012 due to repeated violations of GMP regulations that brought the firm a warning letter from FDA in May.